Aug. 18 at 5:07 PM
$NOW $FN $APP $AMLX ServiceNow benefits from enterprise software and AI adoption, FN remains speculative, AppLovin benefits from mobile advertising and software monetization, and Amylyx advances treatments for neurological diseases. I'm watching enterprise spending, funding, ad growth, and clinical milestones.